ArticleCancer management and research2021

Changes in Carcinoid Syndrome Symptoms Among Patients Receiving Telotristat Ethyl in US Clinical Practice: Findings from the TELEPRO-II Real-World Study.

Matthew H Kulke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.